PRTFDC1 Antikörper (N-Term)
Kurzübersicht für PRTFDC1 Antikörper (N-Term) (ABIN2783533)
Target
Alle PRTFDC1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Sequenz
- AGSSEEAPDY GRGVVIMDDW PGYDLNLFTY PQHYYGDLEY VLIPHGIIVD
-
Homologie
- Human: 100%, Pig: 100%, Rat: 86%
-
Produktmerkmale
- This is a rabbit polyclonal antibody against PRTFDC1. It was validated on Western Blot using a cell lysate as a positive control.
-
Aufreinigung
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the N terminal region of human PRTFDC1
-
-
-
-
Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
-
Kommentare
-
Antigen size: 225 AA
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- PRTFDC1 (phosphoribosyl Transferase Domain Containing 1 (PRTFDC1))
-
Andere Bezeichnung
- PRTFDC1
-
Hintergrund
-
PRTFDC1 belongs to the purine/pyrimidine phosphoribosyltransferase family. Epigenetic silencing of PRTFDC1 by hypermethylation of the CpG islands leads to a loss of PRTFDC1 function, which might be involved in squamous cell oral carcinogenesis.
Alias Symbols: FLJ11888, HHGP
Protein Interaction Partner: LGALS9B, EEF2KMT, MCMBP, GNPDA1, EPM2AIP1, TCL1A, HPRT1, UBC, RTN3, FLAD1, NIF3L1, DTNB, STAT5A, EWSR1,
Protein Size: 225 -
Molekulargewicht
- 26 kDa
-
Gen-ID
- 56952
-
NCBI Accession
- NM_020200, NP_064585
-
UniProt
- Q9NRG1
-
Pathways
- Ribonucleoside Biosynthetic Process
Target
-